REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/20/2026
Back to search
Official data from USPTO
SOVEREIGN PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SOVEREIGN PHARMACEUTICALS
ST13
US500000090275012Class
40, 42
Filing
90275012
Registration
6425133
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
07/20/2026
Trademark type
Word
Nice classes
40, 42
Filing date
10/23/2020
Registration date
07/20/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/20/2021
Last transaction
07/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/04/2013
First use in commerce
06/04/2013
Drawing code
4
Owner type
16
Owner location
Ft. Worth, TX, US
Examiner
BHUPATHI, TARA
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sovereign Pharmaceuticals, LLC
Representatives
Neil C. Jones NELSON MULLINS RILEY & SCARBOROUGH LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of pharmaceutical preparations; Manufacturing services for others in the field of pharmaceutical products
Class 42
Pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/29/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/29/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/29/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/29/2021
DOCK
ASSIGNED TO EXAMINER
03/24/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/03/2021
ALIE
ASSIGNED TO LIE
02/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/28/2020
NWAP
NEW APPLICATION ENTERED
10/27/2020
Continuous trademark protection
Get notified about every new filing that threatens SOVEREIGN PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.